DHA Supplementation during Pregnancy in Women with Obesity Normalizes IGF2R Levels in the Placenta of Male Newborns

Introduction. Insulin-like growth factor receptor 2 (IGF2R) regulates placental nutrient transport, and its soluble form is related to obesity in adults. If the placental expression of IGF2R is altered in women with obesity is unknown. Whether maternal supplementation with docosahexaenoic acid (DHA)...

Full description

Bibliographic Details
Main Authors: Juan José Castro, Adriana Umana-Perez, Erika Castaño-Moreno, Paola Casanello, Ana María Ronco
Format: Article
Language:English
Published: Hindawi Limited 2023-01-01
Series:International Journal of Endocrinology
Online Access:http://dx.doi.org/10.1155/2023/1515033
_version_ 1797787414886875136
author Juan José Castro
Adriana Umana-Perez
Erika Castaño-Moreno
Paola Casanello
Ana María Ronco
author_facet Juan José Castro
Adriana Umana-Perez
Erika Castaño-Moreno
Paola Casanello
Ana María Ronco
author_sort Juan José Castro
collection DOAJ
description Introduction. Insulin-like growth factor receptor 2 (IGF2R) regulates placental nutrient transport, and its soluble form is related to obesity in adults. If the placental expression of IGF2R is altered in women with obesity is unknown. Whether maternal supplementation with docosahexaenoic acid (DHA), a polyunsaturated fatty acid with anti-inflammatory properties, has a modulatory role in IGF2R’s function has not been elucidated. We hypothesized that maternal obesity (Ob) would be associated with alterations in placental IGF2R expression, which may be prevented with DHA supplementation during pregnancy. Methods. At delivery, we obtained placentas from women with Ob (BMI ≥ 30 kg/m2, n = 17), Ob supplemented with 800 mg/day of DHA during pregnancy (Ob + DHA, n = 13), and normal-weight women (Nw, BMI ≥ 18.5 ≤ 24.9 kg/m2, n = 14). The IGF2R mRNA and protein were determined by RT-PCR and western blotting, respectively. Moreover, we quantified the gene expression of molecules that modulate the IGF2R function in the extracellular domain, such as TACE/ADAM17, PLAU, and IGF2. Mann–Whitney and Kruskal–Wallis nonparametric tests were used to compare results between two or three groups accordingly. Results. The IGF2R levels in the Ob placentas of the male offspring were higher than in the Nw group. The DHA supplementation prevented this effect, suggesting an unknown relationship between IGF2R-Ob-DHA in placental tissues. Conclusion. We report, for the first time, that DHA supplementation during pregnancy in women with obesity normalizes the increased IGF2R levels in male placentas, reducing the risk of adverse outcomes related to the IGF2/IGF2R system in male newborns.
first_indexed 2024-03-13T01:21:36Z
format Article
id doaj.art-a456252c0a4749c0bf17b0b99c027e79
institution Directory Open Access Journal
issn 1687-8345
language English
last_indexed 2024-03-13T01:21:36Z
publishDate 2023-01-01
publisher Hindawi Limited
record_format Article
series International Journal of Endocrinology
spelling doaj.art-a456252c0a4749c0bf17b0b99c027e792023-07-05T00:00:06ZengHindawi LimitedInternational Journal of Endocrinology1687-83452023-01-01202310.1155/2023/1515033DHA Supplementation during Pregnancy in Women with Obesity Normalizes IGF2R Levels in the Placenta of Male NewbornsJuan José Castro0Adriana Umana-Perez1Erika Castaño-Moreno2Paola Casanello3Ana María Ronco4Departamento de QuímicaDepartamento de QuímicaLaboratory of Nutrition and Metabolic RegulationDepartment of Neonatology and Department of ObstetricsLaboratory of Nutrition and Metabolic RegulationIntroduction. Insulin-like growth factor receptor 2 (IGF2R) regulates placental nutrient transport, and its soluble form is related to obesity in adults. If the placental expression of IGF2R is altered in women with obesity is unknown. Whether maternal supplementation with docosahexaenoic acid (DHA), a polyunsaturated fatty acid with anti-inflammatory properties, has a modulatory role in IGF2R’s function has not been elucidated. We hypothesized that maternal obesity (Ob) would be associated with alterations in placental IGF2R expression, which may be prevented with DHA supplementation during pregnancy. Methods. At delivery, we obtained placentas from women with Ob (BMI ≥ 30 kg/m2, n = 17), Ob supplemented with 800 mg/day of DHA during pregnancy (Ob + DHA, n = 13), and normal-weight women (Nw, BMI ≥ 18.5 ≤ 24.9 kg/m2, n = 14). The IGF2R mRNA and protein were determined by RT-PCR and western blotting, respectively. Moreover, we quantified the gene expression of molecules that modulate the IGF2R function in the extracellular domain, such as TACE/ADAM17, PLAU, and IGF2. Mann–Whitney and Kruskal–Wallis nonparametric tests were used to compare results between two or three groups accordingly. Results. The IGF2R levels in the Ob placentas of the male offspring were higher than in the Nw group. The DHA supplementation prevented this effect, suggesting an unknown relationship between IGF2R-Ob-DHA in placental tissues. Conclusion. We report, for the first time, that DHA supplementation during pregnancy in women with obesity normalizes the increased IGF2R levels in male placentas, reducing the risk of adverse outcomes related to the IGF2/IGF2R system in male newborns.http://dx.doi.org/10.1155/2023/1515033
spellingShingle Juan José Castro
Adriana Umana-Perez
Erika Castaño-Moreno
Paola Casanello
Ana María Ronco
DHA Supplementation during Pregnancy in Women with Obesity Normalizes IGF2R Levels in the Placenta of Male Newborns
International Journal of Endocrinology
title DHA Supplementation during Pregnancy in Women with Obesity Normalizes IGF2R Levels in the Placenta of Male Newborns
title_full DHA Supplementation during Pregnancy in Women with Obesity Normalizes IGF2R Levels in the Placenta of Male Newborns
title_fullStr DHA Supplementation during Pregnancy in Women with Obesity Normalizes IGF2R Levels in the Placenta of Male Newborns
title_full_unstemmed DHA Supplementation during Pregnancy in Women with Obesity Normalizes IGF2R Levels in the Placenta of Male Newborns
title_short DHA Supplementation during Pregnancy in Women with Obesity Normalizes IGF2R Levels in the Placenta of Male Newborns
title_sort dha supplementation during pregnancy in women with obesity normalizes igf2r levels in the placenta of male newborns
url http://dx.doi.org/10.1155/2023/1515033
work_keys_str_mv AT juanjosecastro dhasupplementationduringpregnancyinwomenwithobesitynormalizesigf2rlevelsintheplacentaofmalenewborns
AT adrianaumanaperez dhasupplementationduringpregnancyinwomenwithobesitynormalizesigf2rlevelsintheplacentaofmalenewborns
AT erikacastanomoreno dhasupplementationduringpregnancyinwomenwithobesitynormalizesigf2rlevelsintheplacentaofmalenewborns
AT paolacasanello dhasupplementationduringpregnancyinwomenwithobesitynormalizesigf2rlevelsintheplacentaofmalenewborns
AT anamariaronco dhasupplementationduringpregnancyinwomenwithobesitynormalizesigf2rlevelsintheplacentaofmalenewborns